Podcasts Health & Fitness Medicine FOAMcast - An Emergency Medicine Podcast Remdesivir - A new open-label trial

Remdesivir - A new open-label trial

Published: Aug. 24, 2020, 6:28 p.m.

b'

We interrupt our normal FOAMcast episodes to bring you updates from COVID-19. *Our understanding of COVID-19 is rapidly developing and this may be out of date in days/weeks. So, check back for updates/fact check what you hear*

We review Spinner et al in JAMA 2020, an open label trial of remdesivir 5 days vs remdesivir 10 days vs \'standard of care\' for the treatment of #COVID19

Show notes:\\xa0FOAMcast.org

Thanks for listening,
Lauren Westafer and Jeremy Faust

'